The increased CD163 expression implies, that monocytes might acquire the alternatively activated anti-inflammatory phenotypes during the manifestation of sepsis, even though a decreased production of inflammatory cytokines was observed in LPS-tolerant human monocytes, regardless of the CD163 or CD206 expression (51). The gene discussed is CD163; the disease is Sepsis.